18
Participants
Start Date
June 26, 2018
Primary Completion Date
June 7, 2021
Study Completion Date
January 31, 2022
Oxaliplatin
Oxaliplatin 60 - 85 mg/m2 IVD 2hr at D1, every 14 days as a cycle till disease progression
Albumin-Bound Paclitaxel /nab-Paclitaxel
150 mg/m2 IVD 30 min bi-weekly.
S-1
Tegafur,oral S-1 35mg/m2 twice daily from D1 to D7, every 14 days as a cycle till disease progression.
LV
LV 30mg twice daily from D1 to D7, every 14 days as a cycle till disease progression
Taiwan Cooperative Oncology Group, National Health Research Institutes, Taipei
National Cheng-Kung University Hospital
OTHER
National Taiwan University Hospital
OTHER
National Health Research Institutes, Taiwan
OTHER